CLINICAL DEVELOPMENT AND COLLABORATION AGREEMENTClinical Development and Collaboration Agreement • October 17th, 2014 • Neothetics, Inc. • Pharmaceutical preparations • New York
THIS CLINICAL DEVELOPMENT AND COLLABORATION AGREEMENT (the “Agreement”) is made effective as of the 2nd day of July, 2013 (the “Effective Date”), by and between NovaMedica, LLC (“NovaMedica”), a limited liability company organized under the laws of the Russian Federation with an address of 107113 bldg. 38, pr. 7, Sokolnichesky Val Street Moscow Russian Federation and Lithera, Inc. (“Lithera” or “Company”), a corporation organized under the laws of the State of Delaware and having its place of business at 9191 Towne Centre Drive, Suite 400, San Diego, California, 92122, USA. For the purposes of this Agreement, “Party” means NovaMedica and Lithera, individually, and “Parties” means NovaMedica and Lithera, collectively.
CLINICAL DEVELOPMENT AND COLLOBORATION AGREEMENTClinical Development and Collaboration Agreement • May 17th, 2013 • Regado Biosciences Inc • Pharmaceutical preparations • New York
THIS CLINICAL DEVELOPMENT AND COLLABORATION AGREEMENT (the “Agreement”) is made effective as of the 14th day of May, 2013 (the “Effective Date”), by and between NovaMedica, LLC (“NovaMedica”), a limited liability company organized under the laws of the Russian federation with an address of 10113 bldg 38, Sokolnichesky Val Street Moscow Russian Federation and Regado Biosciences, Inc. (“Regado” or “Company”), a corporation organized under the laws of the State of Delaware and having its place of business at 120 Mountain View Boulevard, Basking Ridge New Jersey 07920. For the purposes of this Agreement, “Party” means NovaMedica and Regado, individually, and “Parties” means NovaMedica and Regado, collectively.
CLINICAL DEVELOPMENT AND COLLABORATION AGREEMENTClinical Development and Collaboration Agreement • May 12th, 2014 • Marinus Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS CLINICAL DEVELOPMENT AND COLLABORATION AGREEMENT (the “Agreement”) is made effective as of the 25th day of June, 2013 (the “Effective Date”), by and between NovaMedica, LLC (“NovaMedica”), a limited liability company organized under the laws of the Russian Federation with an address of 10113 bldg 38, Sokolnichesky Val Street Moscow Russian Federation, and Marinus Pharmaceuticals, Inc. (“Marinus” or “Company”), a corporation organized under the laws of the State of Delaware, USA, and having its place of business at 142 Temple Street, Suite 205, New Haven, Connecticut 06510, USA. For the purposes of this Agreement, “Party” means NovaMedica and Marinus, individually, and “Parties” means NovaMedica and Marinus, collectively.
